Please provide your email address to receive an email when new articles are posted on . Published results showed lumbar microdiscectomy with a bone-anchored annular closure device for treatment of ...
“Advancing OctaSeal into FDA review represents a significant inflection point, not just for Spinol, but for a market that has been underserved for decades. With only one competitor in a ...
Greg Lambrecht, the founder of Barricaid, said of the new release, "Barricaid Narrow Anchor shortens the learning curve and ease of access for surgeons adopting annular closure, making the benefits of ...
Annular closure devices substantially reduce the risk of needing a reoperation. To reduce the risks of reherniation and reoperation, physicians can consider the use of devices that are implanted into ...
The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...
Spinol Medical(TM) today announced the advancement of its OctaSeal(TM) Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close ...
PR Newswire BOSTON, March 4, 2026 BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid(R) Narrow Anchor, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results